FDA Drug recall D-041-2013
Northstar Zolpidem Tartrate Tablets USP 10 mg
- FDA Drug
- Class II
- terminated
- Published 2012-11-14
On 2012-11-14 the FDA classified a Class II recall of Northstar Zolpidem Tartrate Tablets USP 10 mg by Aurobindo Pharma, citing adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tart….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-041-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-03-09 |
| Published | 2012-11-14 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Aurobindo Pharma |
| Distribution | US |
Product
Northstar Zolpidem Tartrate Tablets USP 10 mg. Manufactured for Northstar RX, LLC Memphis, TN 38141. Manufactured by Aurobindo Pharma Limited, Unit VII, Mahaboob Dagar, 509302, India
Reason
Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg
Identifiers
| code_info | Batch Number ZPSB11054-A Exp. 05/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-041-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.